From 9828fcc0c4dcd49f9444f8fa236098f9171fd431 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Mon, 11 Mar 2024 10:24:02 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Web___Posts.md | 4 ++-- 1 file changed, 2 insertions(+), 2 deletions(-) diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md index 8d64ce48..1b4da52f 100644 --- a/pages/STOP2030___Web___Posts.md +++ b/pages/STOP2030___Web___Posts.md @@ -3,7 +3,7 @@ - # REALISE study registration - ## Our first, and biggest, clinic trial is registered - #+BEGIN_VERSE - At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), our most ambitious clinical trial, has already been reviewed and approved for publication in clinicaltrials.gov and the Pan African Clinical Trial Registry. - This clinical trial is a Cohort Event Study aimed at evaluating both safety and effectiveness within large populations. We expect to recruit around 20 thousand people. + At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), our most ambitious clinical trial, has been approved for publication in clinicaltrials.gov and the Pan African Clinical Trial Registry. + This clinical trial is a Cohort Event Study aimed at evaluating both the safety and effectiveness of our fixed-dose coformulation of albendazol and ivermectin within large populations. We expect to recruit around 20 thousand people. #+END_VERSE \ No newline at end of file